title: [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
authors.forename: U
authors.initials: U
authors.lastname: von Lüpke
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001804:Blood Transfusion, Autologous / Q000295:instrumentation*; D002809:Chondroitin Sulfates / Q000009:adverse effects / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D006497:Heparan Sulfate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006497:Heparan Sulfate; C035838:danaparoid